As obesity is a low-grade inflammation, and EA has shown to have an anti-obesity effect,26 we measured important inflammatory markers such as TNF-α, IL-6 and CRP, in our patients, during EA treatment. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.